UKS Health Group Limited 04913718 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is is that of a treatment supplier to the medico-legal industry. Digita Accounts Production Advanced 6.30.9574.0 true false 04913718 2023-04-01 2024-03-31 04913718 2024-03-31 04913718 core:CurrentFinancialInstruments 2024-03-31 04913718 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 04913718 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 04913718 core:FurnitureFittingsToolsEquipment 2024-03-31 04913718 core:LandBuildings 2024-03-31 04913718 core:OtherPropertyPlantEquipment 2024-03-31 04913718 bus:SmallEntities 2023-04-01 2024-03-31 04913718 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 04913718 bus:FilletedAccounts 2023-04-01 2024-03-31 04913718 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 04913718 bus:RegisteredOffice 2023-04-01 2024-03-31 04913718 bus:CompanySecretaryDirector1 2023-04-01 2024-03-31 04913718 bus:Director2 2023-04-01 2024-03-31 04913718 bus:Director3 2023-04-01 2024-03-31 04913718 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 04913718 bus:Agent1 2023-04-01 2024-03-31 04913718 core:FurnitureFittings 2023-04-01 2024-03-31 04913718 core:FurnitureFittingsToolsEquipment 2023-04-01 2024-03-31 04913718 core:LandBuildings 2023-04-01 2024-03-31 04913718 core:LeaseholdImprovements 2023-04-01 2024-03-31 04913718 core:OfficeEquipment 2023-04-01 2024-03-31 04913718 core:OtherPropertyPlantEquipment 2023-04-01 2024-03-31 04913718 core:PlantMachinery 2023-04-01 2024-03-31 04913718 1 2023-04-01 2024-03-31 04913718 countries:EnglandWales 2023-04-01 2024-03-31 04913718 2023-03-31 04913718 core:FurnitureFittingsToolsEquipment 2023-03-31 04913718 core:LandBuildings 2023-03-31 04913718 core:OtherPropertyPlantEquipment 2023-03-31 04913718 2022-04-01 2023-03-31 04913718 2023-03-31 04913718 core:CurrentFinancialInstruments 2023-03-31 04913718 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 04913718 core:Non-currentFinancialInstruments core:AfterOneYear 2023-03-31 04913718 core:FurnitureFittingsToolsEquipment 2023-03-31 04913718 core:LandBuildings 2023-03-31 04913718 core:OtherPropertyPlantEquipment 2023-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 04913718

UKS Health Group Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 March 2024

 

UKS Health Group Limited

Contents

Company Information

1

Accountants' Report

2

Balance Sheet

3

Notes to the Unaudited Financial Statements

4 to 9

 

UKS Health Group Limited

Company Information

Directors

Mrs Victoria Simister

Mr Gordon Simister

Mr Michael Simister

Company secretary

Mrs Victoria Simister

Registered office

61 Washway Road
Sale
Manchester
M33 7SS

Accountants

Williamson Croft Accountants Limited
Chartered Certified Accountants
York House
20 York Street
Manchester
M2 3BB

 

Chartered Certified Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
UKS Health Group Limited
for the Year Ended 31 March 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of UKS Health Group Limited for the year ended 31 March 2024 as set out on pages 3 to 9 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at https://www.accaglobal.com/gb/en/member/standards/rules-and-standards/rulebook.html.

This report is made solely to the Board of Directors of UKS Health Group Limited, as a body, in accordance with the terms of our engagement letter dated 03 December 2024. Our work has been undertaken solely to prepare for your approval the accounts of UKS Health Group Limited and state those matters that we have agreed to state to the Board of Directors of UKS Health Group Limited, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/gb/en/technical-activities/technical-resources-search/2009/
october/factsheet-163-audit-exempt-companies.html. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than UKS Health Group Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that UKS Health Group Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of UKS Health Group Limited. You consider that UKS Health Group Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of UKS Health Group Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

Williamson Croft Accountants Limited
Chartered Certified Accountants
York House
20 York Street
Manchester
M2 3BB

13 January 2025

 

UKS Health Group Limited

(Registration number: 04913718)
Balance Sheet as at 31 March 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

416,102

463,219

Current assets

 

Debtors

5

2,407,141

2,198,941

Cash at bank and in hand

 

212,993

29,497

 

2,620,134

2,228,438

Creditors: Amounts falling due within one year

6

(2,022,308)

(1,509,921)

Net current assets

 

597,826

718,517

Total assets less current liabilities

 

1,013,928

1,181,736

Creditors: Amounts falling due after more than one year

6

(145,013)

(308,960)

Provisions for liabilities

(16,602)

(21,775)

Net assets

 

852,313

851,001

Capital and reserves

 

Called up share capital

7

100

100

Retained earnings

852,213

850,901

Shareholders' funds

 

852,313

851,001

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the Board on 13 January 2025 and signed on its behalf by:
 

.........................................
Mr Gordon Simister
Director

 

UKS Health Group Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
61 Washway Road
Sale
Manchester
M33 7SS
United Kingdom

These financial statements were authorised for issue by the Board on 13 January 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The financial statements are presented in sterling which is the functional currency of the company.

Summary of disclosure exemptions

The accounts do not include a cash flow statement because the company, as a small reporting entity, is exempt from the requirements to prepare such a statement.

Key sources of estimation uncertainty

In the application of the company's accounting policies, management is required to make judgements, estimates and assumptions about the carrying value of assets and liabilities that are not readily apparent from other sources. The estimates and underlying assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future period..

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of returns, rebates and discounts.

Turnover is generated from the sale, service and rental of mobility scooters and is recognised when goods are
delivered and legal title is passed.

 

UKS Health Group Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Leasehold Improvements

Straight line, 5% on cost

Plant and Machinery

Straight line,10% on cost

Fixtures and Fittings

Straight line,10% on cost

Office Equipment

Straight line, 33% on cost

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

UKS Health Group Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 26 (2023 - 26).

 

UKS Health Group Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

4

Tangible assets

Land and buildings
£

Furniture, fittings and equipment
 £

Other tangible assets
£

Total
£

Cost or valuation

At 1 April 2023

528,527

88,393

155,141

772,061

At 31 March 2024

528,527

88,393

155,141

772,061

Depreciation

At 1 April 2023

152,407

69,137

87,298

308,842

Charge for the year

26,426

5,177

15,514

47,117

At 31 March 2024

178,833

74,314

102,812

355,959

Carrying amount

At 31 March 2024

349,694

14,079

52,329

416,102

At 31 March 2023

376,120

19,256

67,843

463,219

Included within the net book value of land and buildings above is £349,694 (2023 - £376,120) in respect of long leasehold land and buildings.
 

 

UKS Health Group Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

5

Debtors

Current

Note

2024
£

2023
£

Trade debtors

 

1,126,698

937,811

Amounts owed by related parties

1,236,000

1,200,000

Prepayments and Accrued Income

 

44,443

60,350

Other debtors

 

-

780

   

2,407,141

2,198,941

6

Creditors

Creditors: amounts falling due within one year

Note

2024
£

2023
£

Due within one year

 

Loans and borrowings

242,388

497,465

Trade creditors

 

968,684

568,063

Taxation and social security

 

126,484

51,695

Accruals and deferred income

 

635,609

295,926

Other creditors

 

49,143

96,772

 

2,022,308

1,509,921

Included within loans and borrowings less than one year is £142,393 (2023: £397,469). This relates to an invoice finance facility which is secured by way of a fixed and floating charge and negative pledge.

Creditors: amounts falling due after more than one year

Note

2024
£

2023
£

Due after one year

 

Loans and borrowings

145,013

245,009

Other non-current financial liabilities

 

-

63,951

 

145,013

308,960

 

UKS Health Group Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

7

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary A of £1 each

50

50

50

50

Ordinary B of £1 each

10

10

10

10

Ordinary C of £1 each

10

10

10

10

Ordinary D of £1 each

30

30

30

30

100

100

100

100

8

Parent and ultimate parent undertaking

The company's immediate parent is Simister Holdings Ltd, incorporated in England and Wales.

 

The immediate parent's registered office is 61 Washway Road, Sale, United Kingdom, M33 7SS.

9

Off-balance sheet arrangements

Operating Lease Commitments
At year end the total operating lease commitments that are not shown on the balance sheet were £Nil (2023: £16,039).